BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35170472)

  • 1. Cutaneous Neurocristic Hamartoma Mimicking Basal Cell Carcinoma in a Patient With Xeroderma Pigmentosum.
    Finberg A; Martin S; Gradecki S; Zlotoff B; Raghavan SS
    Am J Dermatopathol; 2022 May; 44(5):e54-e56. PubMed ID: 35170472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating Neurocristic Hamartoma Arising in a Giant Congenital Nevus: Comparative Genomic Hybridization Findings.
    Garrido MC; Maroñas-Jiménez L; Ruano Y; Rodriguez-Peralto JL
    Am J Dermatopathol; 2019 Jun; 41(6):438-442. PubMed ID: 30461421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas. A melanocytic tumor morphologically and biologically distinct from common melanoma.
    Pearson JP; Weiss SW; Headington JT
    Am J Surg Pathol; 1996 Jun; 20(6):665-77. PubMed ID: 8651345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocristic cutaneous hamartoma: a distinctive dermal melanocytosis with an unknown malignant potential.
    Mezebish D; Smith K; Williams J; Menon P; Crittenden J; Skelton H
    Mod Pathol; 1998 Jun; 11(6):573-8. PubMed ID: 9647596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital neurocristic cutaneous hamartoma with poliosis: A case report.
    Wilson LM; Beasley KJ; Sorrells TC; Johnson VV
    J Cutan Pathol; 2017 Nov; 44(11):974-977. PubMed ID: 28802002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent squamous cell carcinoma and a novel mutation in a patient with xeroderma pigmentosum: a case report.
    Şahin EA; Taşkıran EZ; Kiper PÖŞ; Aydın B; Utine E
    J Med Case Rep; 2022 Jul; 16(1):306. PubMed ID: 35902966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal cell carcinoma in a child with xeroderma pigmentosum: Clinical response with electron beam radiation therapy.
    Sahai P; Singh K; Sharma S; Kashyap S; Mohanti BK
    Indian J Dermatol Venereol Leprol; 2013; 79(4):533-5. PubMed ID: 23760329
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of vismodegib for the treatment of multiple basal cell carcinomas in a patient with xeroderma pigmentosum.
    Soura E; Plaka M; Dessinioti C; Chasapi V; Stefanaki C; Antoniou C; Stratigos A
    Pediatr Dermatol; 2018 Nov; 35(6):e334-e336. PubMed ID: 30178564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
    Grampurohit VU; Dinesh US; Rao R
    J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma derived from epidermal cyst of the knee of a patient with xeroderma pigmentosum group C.
    Yamanaka K; Sato K; Masaki T; Nakano E; Nishigori C
    J Dermatol; 2022 Jul; 49(7):e246-e247. PubMed ID: 35411966
    [No Abstract]   [Full Text] [Related]  

  • 11. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
    J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
    Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
    J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A young woman with xeroderma pigmentosum complementation group F and a morphoeic basal cell carcinoma.
    Itoh T; Watanabe H; Yamaizumi M; Ono T
    Br J Dermatol; 1995 Jan; 132(1):122-7. PubMed ID: 7756123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases.
    Smith KJ; Mezebish D; Williams J; Elgart ML; Skelton HG
    Ann Diagn Pathol; 1998 Aug; 2(4):213-23. PubMed ID: 9845741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
    Yang JQ; Chen XY; Engle MY; Wang JY
    Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal Cell Carcinoma in Cases with or without Xeroderma Pigmentosum.
    Ghartimagar D; Ghosh A; Shrestha SR; Shrestha S; Thapa S; Narasimhan R; Talwar OP
    JNMA J Nepal Med Assoc; 2017; 56(208):432-7. PubMed ID: 29453475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive neurocristic hamartoma with bone marrow involvement.
    Conrad DM; Chaplin A; Walsh NM; Pasternak S
    Am J Dermatopathol; 2010 Jul; 32(5):486-8. PubMed ID: 20414093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiosarcoma arising from the tongue of an 11-year-old girl with xeroderma pigmentosum.
    Olson MT; Puttgen KB; Westra WH
    Head Neck Pathol; 2012 Jun; 6(2):255-7. PubMed ID: 21987224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous neurocristic hamartoma presenting as cutis verticis gyrata.
    Saha D; Kini UA; Kini H
    Am J Dermatopathol; 2014 Mar; 36(3):e66-9. PubMed ID: 23812020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotropic melanoma arising from a neurocristic hamartoma.
    Clements SA; Kelley BF; Rivera L; Greenway HT
    J Cutan Pathol; 2023 Mar; 50(3):197-200. PubMed ID: 36515639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.